Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer

1 Mar 2016

Abstract excerpt

High-grade non-muscle invasive bladder cancer (HG-NMIBC) is a clinically unpredictable disease with greater risks of recurrence and progression relative to their low-intermediate-grade counterparts. The molecular events, including those affecting the epigenome, that characterize this disease entity in the context of tumor development, recurrence, and progression, are incompletely understood. We therefore...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Epigenetics and DNA Methylation
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26929985
DOI: 10.1080/15592294.2016.1154246

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancerPMID 26929985Read ↗

Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder CancerSemantic proximity Read ↗

Identification of Methylated Genes Associated with Aggressive Bladder CancerSemantic proximity Read ↗

Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder CancerSemantic proximity Read ↗

A global profile of gene promoter methylation in treatment-naïve urothelial cancerSemantic proximity Read ↗

A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancerSemantic proximity Read ↗

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networksSemantic proximity Read ↗

Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor MarkersSemantic proximity Read ↗

Alterations of DNA methylome in human bladder cancerSemantic proximity Read ↗

Epigenomic mapping identifies a super-enhancer repertoire that regulates cell identity in bladder cancers through distinct transcription factor networksSemantic proximity Read ↗

Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.Semantic proximity Read ↗

HOXA9, ISL1 and ALDH1A3 methylation patterns as prognostic markers for nonmuscle invasive bladder cancer: Array‐based DNA methylation and expression profilingSemantic proximity Read ↗

Integrative epigenomic analysis of differential DNA methylation in urothelial carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.